Descurainia sophia is a member of the family Brassicaceae. Common names include flixweed, herb-Sophia and tansy mustard.
Flixweed is a bushy, much‐branched plant that grows up to 2 or more feet tall.
In Iran, the seeds are called khak-e shir (khakshir), and khak-e shir drinks are traditionally favored as thirst quencher during hot summer days. Khakshir is also considered a medicinal substance in traditional Iranian medicine, consumed in varying combinations with other herbs and substances to gain effects ranging from antidiuretic to aphrodisiac. Flixweed originally grew in on the steppes of Western Asia but it has followed people across Europe as far as Finland. The plant is self-fertile.
Common Name(s) | Flixweed |
Scientific Name | Descurainia sophia |
Days to Harvest | 120-150 days |
Harvesting time | July |
Light | Full sun |
Water | Regular |
Soil | Sandy loam, loam |
Temperature | No lower than 60ºF (15ºC) |
Fertilizer | - |
Pests | - |
Diseases | - |
Khakshir is also considered a medicinal substance in traditional Iranian medicine, consumed in varying combinations with other herbs and substances to gain effects ranging from antidiuretic to aphrodisiac.
Medicinal uses
Interactions
Since Descurainia Sophia is used extensively in herbal medicine, it is important to address its drug-metabolizing-enzyme (DME) activities. Assaying enzyme activity shows that EEDS is an inhibitor with a moderate effect on CYP1A2, CYP2C9, and CYP2C19. Since CYP1A2, CYP2C9, and CYP2C19 are major enzymes to many vital processes, such as metabolism of endogenous compounds and elimination of environmental toxins, it is essential to consider the dosage, duration, and interactions when using Descurainia Sophia. Many nonsteroidal anti-inflammatory drugs (NSAID) are a substrate for CYP2C9, including celecoxib, diclofenac, ibuprofen, or naproxen. As Descurainia Sophia seeds are clinically used in the herbal formulation for anti-inflammation or treating respiratory diseases, Descurainia Sophia seeds and NSAID will compete to bind with CYP2C9. The substrates for CYP1A2 include amitriptyline and erlotinib. The substrates for CYP2C9 include ibuprofen, warfarin, and tamoxifen. The substrates for CYP2C19 include diazepam, mephenytoin, methadone and bortezomib. Clinically, the potential adverse effects of DS-drug interactions should be considered when using Descurainia Sophia in combination with drugs that are metabolized by CYP1A2, CYP2C9, or CYP2C19.
Composition
Figures in grams (g) or miligrams (mg) per 100g of food.
Seed (Dry weight)
Address: B23-2, Khayam Complex, Hormozan St., Phase 2, Sanat Sq., Tehran, Iran
Tel: +98 21 88 08 77 01
Mobile: +98 912 502 51 47
All services and products of this site, as the case may be, have the necessary licenses from the relevant authorities and the activities of this site are subject to the laws and regulations of the Islamic Republic of Iran